These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36087627)

  • 21. Improved compression properties of propyphenazone spherical crystals.
    Di Martino P; Di Cristofaro R; Barthélémy C; Joiris E; Palmieri Filippo G; Sante M
    Int J Pharm; 2000 Mar; 197(1-2):95-106. PubMed ID: 10704797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
    McCarron PA; Donnelly RF; Marouf W
    J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation of cilostazol spherical agglomerates by crystallo-co-agglomeration technique and optimization using design of experimentation.
    Deshkar SS; Borde GR; Kale RN; Waghmare BA; Thomas AB
    Int J Pharm Investig; 2017; 7(4):164-173. PubMed ID: 29692975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards a better understanding of the role of stabilizers in QESD crystallizations.
    Hansen J; Kleinebudde P
    Pharm Res; 2022 Dec; 39(12):3123-3136. PubMed ID: 35266086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.
    El-Gendy N; Pornputtapitak W; Berkland C
    Eur J Pharm Sci; 2011 Nov; 44(4):522-33. PubMed ID: 21964203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spherical crystallization of mebendazole to improve processability.
    Kumar S; Chawla G; Bansal AK
    Pharm Dev Technol; 2008; 13(6):559-68. PubMed ID: 18720249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: Implications for colon cancer prevention.
    Guruswamy S; Rao CV
    Int J Oncol; 2009 Nov; 35(5):1037-43. PubMed ID: 19787257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.
    Sano A; Kuriki T; Kawashima Y; Takeuchi H; Hino T; Niwa T
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):733-9. PubMed ID: 2347016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties.
    Gupta VR; Mutalik S; Patel MM; Jani GK
    Acta Pharm; 2007 Jun; 57(2):173-84. PubMed ID: 17507314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV; Cooma I; Reddy BS; Rao CV
    Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box-Behnken experimental design.
    Garala KC; Patel JM; Dhingani AP; Dharamsi AT
    Int J Pharm; 2013 Aug; 452(1-2):135-56. PubMed ID: 23684660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A New Crystal Engineering Technique for Dissolution Enhancement of Poorly Soluble Drugs Combining Quasi-emulsion and Crystallo-co Agglomeration Methods.
    Makar RR; Latif R; Hosni EA; El Gazayerly ON
    Iran J Pharm Res; 2020; 19(2):219-235. PubMed ID: 33224227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and
    Ravouru N; Penjuri SCB; Damineni S; Muni RL; Poreddy SR
    Turk J Pharm Sci; 2018 Apr; 15(1):7-15. PubMed ID: 32454634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers.
    Kachrimanis K; Nikolakakis I; Malamataris S
    J Pharm Sci; 2000 Feb; 89(2):250-9. PubMed ID: 10688754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spherical crystallization: A technique use to reform solubility and flow property of active pharmaceutical ingredients.
    Chatterjee A; Gupta MM; Srivastava B
    Int J Pharm Investig; 2017; 7(1):4-9. PubMed ID: 28405573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the mechanisms of formation of spherical agglomerates.
    Thati J; Rasmuson AC
    Eur J Pharm Sci; 2011 Mar; 42(4):365-79. PubMed ID: 21216285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex methodology for rational design of Apremilast-benzoic acid co-crystallization process.
    Jirát J; Ondo D; Babor M; Ridvan L; Šoóš M
    Int J Pharm; 2019 Oct; 570():118639. PubMed ID: 31465834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of binder liquid type on spherical crystallization.
    Maghsoodi M; Hajipour A
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1468-75. PubMed ID: 23937581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spherical Crystallization Based on Liquid-Liquid Phase Separation in a Reverse Antisolvent Crystallization Process.
    Gong W; Li P; Rohani S
    J Pharm Sci; 2024 Jun; 113(6):1616-1623. PubMed ID: 38311170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.